In this issue:
Docetaxel ±ganetespib in advanced lung adenocarcinoma
First-in-human evaluation of CO-1686
Standard- vs. high-dose chemo-RT ±cetuximab for stage III NSCLC
Crizotinib vs. chemotherapy in untreated Asian ALK+ NSCLC patients
Pemetrexed to paclitaxel switch after pemetrexed+carboplatin in nonsquamous NSCLC
Cisplatin/etoposide vs. paclitaxel/ carboplatin with RT in locally advanced NSCLC
Cost utility of first-line erlotinib in EGFR-mutant advanced NSCLC
Geographic differences in stage III unresectable NSCLC management
Wiki-based guideline development
Limited resection for NSCLC
What to do when CT shows pulmonary nodule
Surgery with curative intent in oligometastatic disease
Optimal mediastinal lymph node sampling
In vivo confocal endomicroscopy of pleural disease
Please login below to download this issue (PDF)